JAKAVI cpr 15 mg 56 pce
7680621260040
CH-62126
L01EJ01
07.16.1.
Reimbursement limitations:
JAKAVI3
Les thérapies suivantes nécessitent une garantie de prise en charge des frais par l’assureur maladie, …
1 / 3
google
Details
- Product number
- 6212602
- CPT
- -
- Packaging group
- 56
- Unit
- Tablette(n)
- Composition
- ruxolitinibum 15 mg ut ruxolitinibi phosphas, lactosum monohydricum 214.35 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, hydroxypropylcellulosum, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium 0.97 mg.
Articles (1)
Jakavi 15 mg, Tabletten
Tabletten
56
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
15.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
214.35 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.97 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 3435.05
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2017
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 62126
- Drug name
- Jakavi, Tabletten
- Galenic form
- TAB
- ATC Code
- L01EJ01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 27/12/2012
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- JAKAVI cpr 15 mg 56 pce
- Description (DE)
- JAKAVI Tabl 15 mg 56 Stk
- Market launch
- 27/12/2012
- Narcotic (BTM)
- No